{"organizations": [], "uuid": "d3d9b01454afa35ff195fa2ad13bc42278ff0009", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-biocryst-advancing-potential-treat/brief-biocryst-advancing-potential-treatment-for-rare-and-severely-debilitating-fibrodysplasia-ossificans-progressiva-idUSFWN1P00FN", "country": "US", "domain_rank": 408, "title": "BRIEF-Biocryst Advancing Potential Treatment For Rare And Severely Debilitating Fibrodysplasia Ossificans Progressiva", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-05T13:06:00.000+02:00", "replies_count": 0, "uuid": "d3d9b01454afa35ff195fa2ad13bc42278ff0009"}, "author": "", "url": "https://www.reuters.com/article/brief-biocryst-advancing-potential-treat/brief-biocryst-advancing-potential-treatment-for-rare-and-severely-debilitating-fibrodysplasia-ossificans-progressiva-idUSFWN1P00FN", "ord_in_thread": 0, "title": "BRIEF-Biocryst Advancing Potential Treatment For Rare And Severely Debilitating Fibrodysplasia Ossificans Progressiva", "locations": [], "entities": {"persons": [{"name": "debilitatin", "sentiment": "negative"}], "locations": [], "organizations": [{"name": "biocryst pharmaceuticals", "sentiment": "none"}, {"name": "biocryst pharmaceuticals inc", "sentiment": "none"}, {"name": "fibrodysplasia ossificans progressiva reuters", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 08 AM / in 5 minutes BRIEF-Biocryst Advancing Potential Treatment For Rare And Severely Debilitating Fibrodysplasia Ossificans Progressiva Reuters Staff \nJan 5 (Reuters) - Biocryst Pharmaceuticals Inc: \n* BIOCRYST ADVANCING POTENTIAL TREATMENT FOR RARE AND SEVERELY DEBILITATING FIBRODYSPLASIA OSSIFICANS PROGRESSIVA \n* BIOCRYST PHARMACEUTICALS - IND FOR NONCLINICAL DEVELOPMENT OF BCX9250,BCX9499 INITIATED WITH GOAL OF PROGRESSING TO PHASE 1 CLINICAL TRIALS IN H1 2019 Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-01-05T13:06:00.000+02:00", "crawled": "2018-01-05T13:20:51.026+02:00", "highlightTitle": ""}